| Carlos Enrique Carranza, MD | |
|
212 S Florida St, Bushnell, FL 33513-6703 | |
| (352) 787-1600 | |
| (352) 793-3282 |
| Full Name | Carlos Enrique Carranza |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Location | 212 S Florida St, Bushnell, Florida |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689777955 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | ACN1062 (Florida) | Primary |
| Entity Name | Lowell F. Clark Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629278882 PECOS PAC ID: 7416918370 Enrollment ID: O20041023000143 |
News Archive
Bone marrow transplantation is a life-saving therapy for patients with blood cancers like leukemia or lymphoma. However, the depletion of the patient's immune system prior to transplantation can put patients at risk of for an infection by a virus called cytomegalovirus (CMV) that can be life threatening in these immune-compromised individuals.
Foresight Diagnostics, the emerging leader in blood-based lymphoma disease monitoring, announced today that clinical performance of its minimal residual disease (MRD) detection platform in diffuse large B-cell lymphoma (DLBCL) will be presented at the 16th International Conference on Malignant Lymphoma (ICML) on June 18-22, 2021.
Researchers presenting at ECCMID have warned that vector-borne diseases are on the rise and threatening to spread into many parts of Europe.
Neuroptis Biotech, the ophthalmology drug research and development specialist, announces positive results in preclinical trials of the eye-drop formulation of its ML7 product. ML7 is intended for use in the treatment of eye surface diseases, particularly dry eye.
› Verified 6 days ago
| Entity Name | Centro Medico Del Turabo Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710107883 PECOS PAC ID: 9335051952 Enrollment ID: O20080212000105 |
News Archive
Bone marrow transplantation is a life-saving therapy for patients with blood cancers like leukemia or lymphoma. However, the depletion of the patient's immune system prior to transplantation can put patients at risk of for an infection by a virus called cytomegalovirus (CMV) that can be life threatening in these immune-compromised individuals.
Foresight Diagnostics, the emerging leader in blood-based lymphoma disease monitoring, announced today that clinical performance of its minimal residual disease (MRD) detection platform in diffuse large B-cell lymphoma (DLBCL) will be presented at the 16th International Conference on Malignant Lymphoma (ICML) on June 18-22, 2021.
Researchers presenting at ECCMID have warned that vector-borne diseases are on the rise and threatening to spread into many parts of Europe.
Neuroptis Biotech, the ophthalmology drug research and development specialist, announces positive results in preclinical trials of the eye-drop formulation of its ML7 product. ML7 is intended for use in the treatment of eye surface diseases, particularly dry eye.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Carlos Enrique Carranza, MD 212 S Fla St, Bushnell, FL 33513-6703 Ph: (352) 793-2441 | Carlos Enrique Carranza, MD 212 S Florida St, Bushnell, FL 33513-6703 Ph: (352) 787-1600 |
News Archive
Bone marrow transplantation is a life-saving therapy for patients with blood cancers like leukemia or lymphoma. However, the depletion of the patient's immune system prior to transplantation can put patients at risk of for an infection by a virus called cytomegalovirus (CMV) that can be life threatening in these immune-compromised individuals.
Foresight Diagnostics, the emerging leader in blood-based lymphoma disease monitoring, announced today that clinical performance of its minimal residual disease (MRD) detection platform in diffuse large B-cell lymphoma (DLBCL) will be presented at the 16th International Conference on Malignant Lymphoma (ICML) on June 18-22, 2021.
Researchers presenting at ECCMID have warned that vector-borne diseases are on the rise and threatening to spread into many parts of Europe.
Neuroptis Biotech, the ophthalmology drug research and development specialist, announces positive results in preclinical trials of the eye-drop formulation of its ML7 product. ML7 is intended for use in the treatment of eye surface diseases, particularly dry eye.
› Verified 6 days ago
Dr. Angel Gabriel Pagan, M. D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 117 W Belt Ave, Bushnell, FL 33513 Phone: 352-568-1988 | |
Dr. Brendalis Davila Rolon, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 117 W Belt Ave, Bushnell, FL 33513 Phone: 352-568-1988 | |
Daniel D Dstteffano, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 212 S Florida St, Clark Clinic Inc, Bushnell, FL 33513 Phone: 352-793-2441 |